Indivior Submits Products For Approval Outside The US, Where Pressures Mount

 
• By John Davis

Indivior is working on receiving ex-US approvals for its opioid abuse treatment products and building its cash reserves but faces future uncertainty over US generic competition and a US Department of Justice legal action.  

Syringe
The opioid abuse epidemic is sweeping hard-pressed communities. • Source: Shutterstock

More from Neurological

More from Therapy Areas